Strategic Marketing Services for Life Sciences
Here's what usually happens when a life sciences company realises it has a marketing problem: they hire five different specialists. A messaging agency. A positioning consultant. A market access advisor. A sales trainer. A research firm. Each one works in isolation. Each one produces excellent-looking deliverables. And six months later, the company has five separate strategies that don't talk to each other, a sales team that's still telling a different story from the website, and a launch plan that nobody has actually pressure-tested against the regulatory timeline.
I've seen this pattern so many times that I built my practice specifically to break it.
I work across five interconnected disciplines. Most clients need a combination — and that's the point. Messaging without positioning is empty. A launch strategy without sales enablement is incomplete. Voice of customer research that doesn't feed back into positioning is a waste of money. I build integrated strategies that hold together under scrutiny — from the boardroom to the conference booth to the procurement committee.
Every engagement is bespoke. No templates, no filler — a clear strategy and precise tactics built around your product, your market, and your commercial objectives.
Messaging Architecture
Your science is clear to you. But when your sales team explains it to a clinician, your marketing team writes the brochure, and your CEO pitches to investors — the message is different every time. Messaging architecture creates a structured, evidence-based framework that ensures everyone in your organisation tells the same story — consistently, compellingly, and accurately. I've built messaging frameworks that sales teams actually use, not decks that gather dust in a shared drive.
Typical outcome: A complete messaging architecture document with audience-specific narratives, objection handling, and channel-adapted messaging your team can use immediately.
Product Positioning
Most life sciences companies position on features — sensitivity, specificity, throughput, speed. The problem? So does everyone else. When every product leads with the same metrics, the buyer defaults to price. I help you answer a different question: what clinical or operational problem does your product solve that nothing else solves as well? I've repositioned diagnostics products from feature-led to value-led positioning, turning lagging portfolios into double-digit growth.
Typical outcome: A defensible positioning statement, competitive landscape analysis, and payer/procurement framing that your whole organisation can rally around.
Go-to-Market Strategy
A brilliant product with a poor go-to-market strategy fails slowly. In life sciences, where development cycles are long and launch windows are narrow, your commercial strategy needs to be as rigorous as the science behind it. I've led GTM strategies across the UK, EU, and Japan — including multi-market launches that had to navigate parallel regulatory pathways while maintaining consistent positioning. If you're waiting until regulatory approval to start commercial planning, you've already lost 6-12 months.
Typical outcome: An end-to-end commercialisation plan covering market access, channel strategy, launch sequencing, KOL engagement, and competitive response planning.
Sales Enablement
Marketing creates beautiful materials. Sales needs practical tools. The gap between the two is where deals die. I bridge that gap — translating strategic positioning into playbooks, evidence toolkits, competitive battle cards, and ROI calculators that your commercial team will actually pick up and use. I've built sales enablement materials that drove a 21% lead capture rate at a major medical conference and equipped teams to handle procurement committee questions about health economics.
Typical outcome: A complete sales toolkit with structured buyer-type guides, objection handling frameworks, competitive battle cards, and clinical evidence presentation tools.
Voice of Customer & CX Analytics
In life sciences, customer insight isn't a nice-to-have — it's the foundation of every strategic decision. Who are your customers? What do they actually value? How do they make decisions? What would make them switch? These aren't questions you can answer from inside your organisation. I bring deep expertise in pharmaceutical CX analytics — from customer engagement scoring and omnichannel measurement to HCP research and competitive perception studies. I've designed measurement frameworks used across 12 global markets.
Typical outcome: Evidence-based customer insights, journey maps, and measurement frameworks that shape product strategy and commercial decisions.
How Engagements Work
Discovery (Weeks 1-2): We start with your product, your market, and your challenge. I read your regulatory submissions, clinical data, and competitor landscape. I talk to your team — sales, marketing, medical, R&D. I ask hard questions upfront so the strategy is built on reality, not assumptions. By the end of discovery, I know your science as well as you do.
Strategy (Weeks 3-6): I develop a clear, actionable plan — not a 100-page deck that gathers dust, but a focused strategy your team can execute. Every recommendation comes with a rationale, a deliverable, and a timeline. I present the strategy to your team, pressure-test it against objections, and refine it until it's bulletproof.
Execution Support (Weeks 7+): I stay involved through implementation. Strategies are only as good as their execution, and I've seen too many excellent plans die in the handover. I help with launch coordination, sales training, content development, and performance tracking. Most engagements run 4-8 weeks for focused projects, 12+ weeks for complex launches.
All engagements are project-based with clear scope and deliverables. No retainers, no open-ended contracts, no billable-hours games. You know what you're getting and what it costs before we start.
Who I Work With
My clients tend to fall into a few categories:
- Diagnostics and MedTech companies pre-launch: You've built the product, you're approaching or past regulatory approval, and you need a commercial strategy that matches the rigour of your R&D. You might be launching your first product or expanding into new markets
- Biotech companies approaching Series B: Your investors are going to ask about your commercial strategy. You need a credible GTM plan that demonstrates you've thought beyond the science — market sizing, positioning, pricing, channel strategy, evidence roadmap
- Research tools and laboratory equipment providers: You have hundreds or thousands of SKUs with inconsistent positioning and unclear differentiation. You need someone who can make sense of the portfolio and build a scalable commercial framework
- Digital health companies targeting clinicians: You've built a platform that works, but healthcare professionals aren't engaging. You need someone who understands both the clinical scepticism barrier and how to overcome it with evidence-led positioning
- Pharmaceutical teams measuring customer engagement: You're investing heavily in omnichannel but can't prove it's working. You need measurement frameworks, engagement scores, and analytics that connect activity to outcomes
If any of that sounds familiar, let's start a conversation →